US20060165735A1 - Stable emulsions of oils in aqueous solutions and methods for producing same - Google Patents
Stable emulsions of oils in aqueous solutions and methods for producing same Download PDFInfo
- Publication number
- US20060165735A1 US20060165735A1 US10/518,957 US51895705A US2006165735A1 US 20060165735 A1 US20060165735 A1 US 20060165735A1 US 51895705 A US51895705 A US 51895705A US 2006165735 A1 US2006165735 A1 US 2006165735A1
- Authority
- US
- United States
- Prior art keywords
- oil
- emulsion
- product
- oil emulsion
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003921 oil Substances 0.000 title claims abstract description 189
- 239000000839 emulsion Substances 0.000 title claims abstract description 171
- 238000000034 method Methods 0.000 title claims abstract description 39
- 239000007864 aqueous solution Substances 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 49
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 43
- 239000003381 stabilizer Substances 0.000 claims abstract description 35
- 239000000203 mixture Substances 0.000 claims description 52
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 27
- 235000013305 food Nutrition 0.000 claims description 23
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical class CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 19
- 235000010445 lecithin Nutrition 0.000 claims description 19
- 239000000787 lecithin Substances 0.000 claims description 19
- 241000196324 Embryophyta Species 0.000 claims description 18
- 230000000813 microbial effect Effects 0.000 claims description 18
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 15
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 14
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 14
- 229930195729 fatty acid Natural products 0.000 claims description 14
- 239000000194 fatty acid Substances 0.000 claims description 14
- 150000004665 fatty acids Chemical class 0.000 claims description 14
- 229940067606 lecithin Drugs 0.000 claims description 14
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 14
- 150000002148 esters Chemical class 0.000 claims description 13
- 229920000136 polysorbate Polymers 0.000 claims description 13
- 229950008882 polysorbate Drugs 0.000 claims description 13
- 239000000230 xanthan gum Substances 0.000 claims description 12
- 229920001285 xanthan gum Polymers 0.000 claims description 12
- 235000010493 xanthan gum Nutrition 0.000 claims description 12
- 229940082509 xanthan gum Drugs 0.000 claims description 12
- -1 diglycerides Chemical class 0.000 claims description 11
- 239000004615 ingredient Substances 0.000 claims description 11
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 10
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 10
- 230000000845 anti-microbial effect Effects 0.000 claims description 9
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 9
- 235000015165 citric acid Nutrition 0.000 claims description 9
- 239000004302 potassium sorbate Substances 0.000 claims description 9
- 235000010241 potassium sorbate Nutrition 0.000 claims description 9
- 229940069338 potassium sorbate Drugs 0.000 claims description 9
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 9
- 239000004299 sodium benzoate Substances 0.000 claims description 9
- 235000010234 sodium benzoate Nutrition 0.000 claims description 9
- 241001467333 Thraustochytriaceae Species 0.000 claims description 8
- 239000004599 antimicrobial Substances 0.000 claims description 8
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000019634 flavors Nutrition 0.000 claims description 8
- 239000002417 nutraceutical Substances 0.000 claims description 8
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 8
- 241000195493 Cryptophyta Species 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 239000000049 pigment Substances 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 claims description 7
- 241000199914 Dinophyceae Species 0.000 claims description 6
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 6
- 235000013601 eggs Nutrition 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims description 6
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 5
- 229920002101 Chitin Polymers 0.000 claims description 5
- 229920002148 Gellan gum Polymers 0.000 claims description 5
- 108010030975 Polyketide Synthases Proteins 0.000 claims description 5
- 229940072056 alginate Drugs 0.000 claims description 5
- 235000010443 alginic acid Nutrition 0.000 claims description 5
- 229920000615 alginic acid Polymers 0.000 claims description 5
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 5
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 5
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 5
- 230000002538 fungal effect Effects 0.000 claims description 5
- 235000010492 gellan gum Nutrition 0.000 claims description 5
- 239000000216 gellan gum Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000004048 modification Effects 0.000 claims description 5
- 238000012986 modification Methods 0.000 claims description 5
- 239000007764 o/w emulsion Substances 0.000 claims description 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 5
- 229940127557 pharmaceutical product Drugs 0.000 claims description 5
- 235000011007 phosphoric acid Nutrition 0.000 claims description 5
- 235000013772 propylene glycol Nutrition 0.000 claims description 5
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 claims description 4
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 4
- 235000021294 Docosapentaenoic acid Nutrition 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 4
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 4
- 239000004147 Sorbitan trioleate Substances 0.000 claims description 4
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 claims description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 4
- 235000021342 arachidonic acid Nutrition 0.000 claims description 4
- 229940114079 arachidonic acid Drugs 0.000 claims description 4
- 230000000975 bioactive effect Effects 0.000 claims description 4
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 4
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 4
- 229940013317 fish oils Drugs 0.000 claims description 4
- 229960004488 linolenic acid Drugs 0.000 claims description 4
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 4
- 229920000223 polyglycerol Chemical class 0.000 claims description 4
- 229940093625 propylene glycol monostearate Drugs 0.000 claims description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 4
- 235000011076 sorbitan monostearate Nutrition 0.000 claims description 4
- 239000001587 sorbitan monostearate Substances 0.000 claims description 4
- 229940035048 sorbitan monostearate Drugs 0.000 claims description 4
- 235000019337 sorbitan trioleate Nutrition 0.000 claims description 4
- 229960000391 sorbitan trioleate Drugs 0.000 claims description 4
- 241001133760 Acoelorraphe Species 0.000 claims description 3
- 240000004355 Borago officinalis Species 0.000 claims description 3
- 235000007689 Borago officinalis Nutrition 0.000 claims description 3
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 3
- 240000002791 Brassica napus Species 0.000 claims description 3
- 235000011293 Brassica napus Nutrition 0.000 claims description 3
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 3
- 240000000385 Brassica napus var. napus Species 0.000 claims description 3
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 3
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 3
- 244000020518 Carthamus tinctorius Species 0.000 claims description 3
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 3
- 244000020551 Helianthus annuus Species 0.000 claims description 3
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 3
- 241000219925 Oenothera Species 0.000 claims description 3
- 235000004496 Oenothera biennis Nutrition 0.000 claims description 3
- 240000007817 Olea europaea Species 0.000 claims description 3
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 235000004426 flaxseed Nutrition 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 235000021056 liquid food Nutrition 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 claims description 3
- 235000013406 prebiotics Nutrition 0.000 claims description 3
- 239000006041 probiotic Chemical class 0.000 claims description 3
- 230000000529 probiotic effect Effects 0.000 claims description 3
- 235000018291 probiotics Nutrition 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 235000013618 yogurt Nutrition 0.000 claims description 3
- 235000008452 baby food Nutrition 0.000 claims description 2
- 235000015173 baked goods and baking mixes Nutrition 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 235000013339 cereals Nutrition 0.000 claims description 2
- 235000013351 cheese Nutrition 0.000 claims description 2
- 235000015203 fruit juice Nutrition 0.000 claims description 2
- 235000012771 pancakes Nutrition 0.000 claims description 2
- 235000020991 processed meat Nutrition 0.000 claims description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 claims 3
- 235000012054 meals Nutrition 0.000 claims 2
- 235000021055 solid food Nutrition 0.000 claims 2
- 235000011850 desserts Nutrition 0.000 claims 1
- 235000015897 energy drink Nutrition 0.000 claims 1
- 235000013350 formula milk Nutrition 0.000 claims 1
- 235000015243 ice cream Nutrition 0.000 claims 1
- 235000012773 waffles Nutrition 0.000 claims 1
- 230000003647 oxidation Effects 0.000 abstract description 17
- 238000007254 oxidation reaction Methods 0.000 abstract description 17
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 abstract description 16
- 239000000047 product Substances 0.000 description 19
- 239000000126 substance Substances 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 241000233671 Schizochytrium Species 0.000 description 6
- 238000004945 emulsification Methods 0.000 description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 5
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 5
- 229920000053 polysorbate 80 Polymers 0.000 description 5
- 229940068968 polysorbate 80 Drugs 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 241000233675 Thraustochytrium Species 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000000693 micelle Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000199913 Crypthecodinium Species 0.000 description 2
- 241000235575 Mortierella Species 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 241001491678 Ulkenia Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010988 polyoxyethylene sorbitan tristearate Nutrition 0.000 description 2
- 239000001816 polyoxyethylene sorbitan tristearate Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 235000000380 Nyssa aquatica Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920002642 Polysorbate 65 Polymers 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000700141 Rotifera Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000598397 Schizochytrium sp. Species 0.000 description 1
- 241000657513 Senna surattensis Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940099511 polysorbate 65 Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000014438 salad dressings Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical group CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/003—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0053—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/01—Other fatty acid esters, e.g. phosphatides
- A23D7/011—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/017—Mixtures of compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/14—Derivatives of phosphoric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
Definitions
- the present invention is directed to oil-in-water emulsions, and in particular, emulsions that help protect oils from oxidation, especially oils that are susceptible to oxidation.
- oil and polysorbate (or lecithin) and water have been combined to produce an emulsion, but the results have been unsatisfactory.
- Oil and xanthan gum and water mixtures are only temporarily stable, like those found in salad dressings. Emulsification of oil can also be achieved through the addition of water to the oil, combined with strong, lengthy agitation, but the resulting emulsion is very unstable.
- LCPUFA-containing oils in aqueous mixtures, such as aqueous food, cosmetic, pharmaceutical and industrial product matrices, without having the oil and water separate into two distinct phases. It would be advantageous to find ways to stabilize an oil-in-water emulsion over a long period of time, in other words, to form an emulsion that is physically stable (e.g., the oil and the water do not phase separate) for at least 30 days. It would be advantageous if the oil is protected by the emulsion from oxidation, in particular, when the oil is susceptible to oxidation, such as a LCPUFA oil.
- the present invention is directed toward an oil emulsion.
- the emulsion includes an oil component, an emulsifier, an emulsion stabilizer, and water.
- the oil component can include polyunsaturated fatty acids, such as polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons.
- Exemplary oil components include linolenic acid, stearidonic acid, arachidonic acid, eicosapentaenoic acid, docasapentaenoic acid, docosahexaenoic acid and mixtures thereof.
- the oil component can be an oil from plants, genetically modified plants, microbial oils, genetically modified microbial oils, fish oils and mixtures thereof.
- plants can include algae, flaxseeds, rapeseeds, corn, evening primrose, soy, sunflower, safflower, palm, olive, canola, borage, and mixtures thereof.
- the genetic modifications can include the introduction or modification of polyketide synthase genes.
- the oil component can also include an oil from a microbial source such as Thraustochytriales, dinoflagellates, and fungal sources.
- the emulsifier is selected from the group of polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, sodium lauryl sulfate and mixtures thereof
- the emulsifier and the oil can be from the same source.
- the stabilizer can be selected from the group of xanthan gum, alginate, gellan gum, carboxymethylcellulose, chitin and mixtures thereof.
- the weight ratio of the oil component to the emulsifier can be between about 1: 1 and about 99: 1, and is preferably about 6: 1.
- the ratio of water to emulsion stabilizer can be between about 1:0.1 and about 1:0.001.
- the ratio of oil component to water can be between about 2:1 and about 1:25.
- Oil emulsions of the present invention are highly stable and can be physically and/or chemically stable for at least about 30 days.
- the emulsion of the present invention can be an oil-in-water emulsion. Further, the emulsion can be produced without having been heat treated. The emulsion can also have a total bacteria count of less than 20MPN/gram. In other embodiments, the oil emulsion can include an antimicrobial component, such as propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid, citric acid and mixtures thereof.
- an antimicrobial component such as propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid, citric acid and mixtures thereof.
- the emulsion of the present invention can also include functionally active ingredients, such as flavors, pigments, sweeteners and anti-oxidants.
- the emulsion can also include bioactive ingredients, such as vitamins, minerals, pre-biotic compounds, pro-biotic compounds and nutraceuticals.
- inventions include food products, cosmetic products, pharmaceutical products, nutriceutical products, and industrial products that include the oil emulsions of the invention.
- Alternative embodiments of the present invention include a method for forming an emulsion.
- the method includes combining an oil component, an emulsifier, an emulsion stabilizer and water.
- the oil component and emusifier are combined; the emulsion stabilizer and the water are combined; and then, the oil component/emulsifier combination and the emulsion stabilizer/water combination are combined.
- the various components of the emulsion can be combined with high shear mixing.
- an oil emulsion in a preferred embodiment of the present invention, includes an oil component that includes polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons.
- the emulsion further includes an emulsifier, an emulsion stabilizer, water and an antimicrobial component.
- the weight ratio of oil component to emulsifier is between about 1:1 and about 99: 1.
- the ratio of water to emulsion stabilizer is between about 1:0.1 and about 1:0.001.
- the ratio of oil component to water is between about 2:1 and about 1:25.
- This oil emulsion composition is physically and chemically stable for at least about 30 days.
- FIG. 1 is a flowsheet of an example of preparation of an emulsion of the present invention.
- a method for forming stable emulsions, particularly including LCPUFA.
- the method includes the step of mixing at least four ingredients: (1) oil; (2) emulsion stabilizer; (3) emulsifier; and (4) water.
- the resulting emulsion is an oil-in-water emulsion with water as the continuous phase. It is believed that the emulsion stabilizer assists in maintaining the long-term stability of the emulsion without the need to agitate the solution continually for even distribution, preventing the oxidation of the LCPUFA oils and maintaining the integrity of the oils, thereby enhancing a longer shelf life of the product.
- the emulsion is stable for at least 30 days, and more preferably for at least 60 days.
- the resulting emulsions are very stable over a wide range of pH conditions and temperatures, and the LCPUFA oils are highly protected from oxidation.
- These emulsions can exist as stand-alone products and can easily be incorporated into a wide range of products, including food, personal care and industrial products (e.g., human foods, animal feeds, pharmaceuticals, nutraceuticals, cosmetics, industrial products, etc.).
- a particular advantage of the products of the present invention is that they can be uniformly dispersed in a wide variety of end products.
- the oil component of emulsions of the present invention can include any oil, preferably, any vegetable or microbial oil, including for example, oils having LCPUFA.
- Long chain PUFA oils can include any oil containing a fatty acid with at least two, and more preferably three or more double bonds, and a chain length of at least 18 carbons.
- LCPUFA oils examples include oils containing the fatty acids linolenic acid (18:3n-3), stearidonic acid (18:4n-3) arachidonic acid (20:4n-6), eicosapentaenoic acid (20:5n-3), docosapentaenoic acid (22:5n-3 and 22:5n-6) and docosahexaenoic acid (22:6n-3).
- oils include oils from fish oils, microbial oils (e.g.
- Thraustochytriales such as Schizochytrium and Thraustochytrium, from dinoflagellates such as Ctypthecodinium, and from fungal sources such as Mortierella ), plants, and oilseeds, as well as genetically modified fish oils, microbial oils, plants, and oilseeds.
- Sources of fatty acids can include oils from animal, plant and microbial sources.
- oils can include oils from animal, plant and microbial sources.
- the term “oil” is used broadly to include fats and oils in various forms. The oil must be capable of emulsification.
- Preferred oils include triacylglycerol and ethyl ester forms of LCPUFA.
- the oils will be a mixture of different substances, such as triacylglycerols, ethyl esters, free fatty acids, phospholipids, sterols, etc. Such mixtures can be purified, if desired.
- animal sources include aquatic animals (e.g., fish, marine mammals, crustaceans, rotifers, etc.) and oils extracted from animal tissues (e.g., brain, liver, eyes, etc.).
- plant and microbial sources include algae, flaxseeds, rapeseeds, corn, evening primrose, soy, sunflower, safflower, palm, olive, canola and borage.
- a preferred source is aquatic algae such as algae of the order Thraustochytriales , and preferably algae of the genus Thraustochytrium and Schizochytrium. It should be noted that many experts agree that Ulkenia is not a separate genus from Thraustochytrium and Schizochytrium.
- the genera Thraustochytrium and Schizochytrium will include Ulkenia. Information regarding such algae can be found in U.S. Pat. Nos. 5,130,242 and 5,340,594, which are incorporated herein by reference in their entirety. Another preferred source is the dinoflagellate of the genus Crypthecodinium. Information regarding Crypthecodinium can be found in U.S. Pat. Nos. 5,407,957; 5,711,983; 5,397,591; and 5,492,938, which are incorporated herein by reference in their entirety. Information regarding Mortierella can be found in U.S. Pat. Nos. 5,658,767 and 5,583,019, which are incorporated herein by reference in their entirety.
- Plant and microbial sources can include genetically modified plants and microorganisms, and preferably include genetic modified plants and microorganisms with increased or newly introduced production of PUFAs by the introduction or modification of a polyketide synthase system (PKS system).
- PKS system polyketide synthase system
- Oils containing the desired fatty acids can be extracted from the various sources by any suitable means, such as by supercritical fluid extraction or by extraction with solvents such as chloroform, hexane, methylene chloride, methanol and the like.
- the oils can be extracted using extraction techniques, such as are described in U.S. patent application Ser. No. 09/766,500 and PCT Patent Application Serial No. US01/01806, both entitled “Solventless Extraction Process” and both filed Jan. 19, 2001, both of which are incorporated herein by reference in their entirety.
- Lecithins can be extracted by any suitable technique, and are obtainable from many of the same sources from which the oils can be obtained.
- lecithin which is useful as an emulsifier, and oil are obtained from the same source.
- the lecithin and oil may be extracted together, or separately extracted and remixed to form the emulsion. Additional extraction and/or purification techniques are taught in PCT Patent Application Serial No. US01/12047 entitled “Method for the Fractionation of Oil and Polar Lipid-Containing Native Raw Materials” filed Apr. 12, 2001;
- PCT Patent Application Serial No. US01/12849 entitled “Method for the Fractionation of Oil and Polar Lipid-Containing Native Raw Materials Using Water-Soluble Organic Solvent and Centrifugation” filed Apr. 12, 2001;
- the oil is typically present in an amount from about 5 wt. % to about 50 wt. %, more preferably from about I0 wt. % to about 40 wt. %, and even more preferably from about 20 wt. % to about 30 wt. %.
- the emulsifier of emulsions of the present invention can include any emulsifier, including polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, and sodium lauryl sulfate.
- polysorbate esters including polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, and sodium lauryl sulfate.
- a polysorbate ester e.g., polyethylene sorbitan monooleate (Polysorbate 80), polyoxyethylene sorbitan monolaurate (Polysorbate 20), polyoxyethylene sorbitan tristearate (Polysorbate 65) or Polysorbate 60
- the emulsifier can be a lecithin. Lecithins can be extracted from plant seeds, (e.g., soy lecithins), and can be extracted from eggs, milk, microbes or animal sources.
- the emulsifier is typically present in an amount from about 1 wt. % to about 20 wt. %, more preferably from about 8 wt. % to about 15 wt. %, and even more preferably from about 2 wt % to about 6 wt. %.
- the emulsion stabilizer of the present invention functions to further stabilize the emulsion compared to the emulsion in the absence of the stabilizer.
- the stabilizer can also function as a thickener of the emulsion.
- the emulsion stabilizer can be selected from xanthan gum, alginate, gellan gum, carboxymethylcellulose and chitin. In a preferred embodiment of the present invention, xanthan gum is used as the stabilizer.
- the emulsion stabilizer is typically present in an amount from about 10 wt. % to about 2 wt. %, more preferably from about 0.2 wt % to about 0.8 wt. %, and even more preferably from about 0.3 wt. % to about 0.5 wt. %.
- Emulsions of the present invention also include water.
- Water is typically present in an amount from about 80 wt. % to about 90 wt. %, more preferably from about 20 wt % to about 80 wt. %, and even more preferably from about 50 wt. % to about 70 wt. %.
- Emulsions of the present invention are highly stable in terms of both physical stability (i.e., lack of separation of components) and chemical stability (i.e., lack of oxidation of the oil component).
- Physical stability can be measured in a variety of ways. Simple visual observation of physical separation or “creaming” is an indication of separation.
- no observable phase separation occurs after storage at 4 C, and more preferably after storage at room temperature (i.e., about 22 C), within 30 days, more preferably within 90 days, and more preferably within 180 days.
- Another measure of physical stability is a lack of change in the particle size of micelles formed in the emulsion. As emulsions separate, the size of micelles becomes greater. In preferred embodiments of the invention, the particle size of micelles will not increase more than about 15 %, more preferably not more than about 25 %, more preferably not more than about 30 %, more preferably not more than about 40 %, and more preferably not more than about 50 %, after storage at 4 C within 30 days, more preferably within 90 days, and more preferably within 180 days.
- Chemical stability of an emulsion can be measured in terms of oxidation of any of the species of the oil component, including linolenic acid, stearidonic acid, arachidonic acid, eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid.
- Oxidation can be measured by the production of secondary products of oxidation, such as by measuring peroxide values, anisidine values, or alkenal values or by conducting a headspace analysis.
- the value of the measure after storage at room temperature (i.e., about 22 C) for 30 days will increase less than about 20% by 60 days and/or less than about 50% by 90 days.
- the emulsions of the present invention can meet one or more of the physical or chemical stability parameters identified above over a wide range of pH conditions. More specifically, such parameters can be met over a pH range of about 3 to about 8, more preferably from about 3 to about 7, more preferably from about 3 to about 4.
- the emulsions of the present invention can meet one or more of the physical or chemical stability parameters identified above over a wide range of temperature conditions. More specifically, such parameters can be met over a temperature range of up to about room temperature (i.e., about 22 C), emulsions will be most stable at refrigeration temperature of about 4 C.
- Emulsions of the present invention can be prepared by mixing the emulsifier with the oil in an initial step.
- the weight ratio of oil to emulsifier is between about 1:1 and about 99:1, more preferably in a range from about 3:1 to about 50:1, more preferably in a range from about 4:1 to about 25:1, more preferably in a range from about 5:1 to about 10:1, more preferably in a ratio of about 6:1.
- Mixing can be facilitated by heating the mixture, for example, to about 60 C for about 5 minutes, but can also be mixed at room temperature.
- water and an emulsion stabilizer are mixed. Before this step, however, additional components that are water soluble, such as antimicrobial compounds like citric acid, sodium benzoate, and potassium sorbate, can be added to the water.
- a preferred weight ratio of water to emulsion stabilizer is in the range of about 1:0.1 to about 1:0.001, with a more preferred range of about 1:0.05 to about 1:0.005.
- the oil/emulsifier mixture and the water/emulsion stabilizer are then combined.
- these two mixtures are combined to achieve an oil to water ratio of between about 2:1 to about 1:25.
- this combination can be made at room temperature for ease of preparation and to avoid unnecessary temperature stress on the oil.
- mild heating e.g., 35 C to 40 C
- Mixing of the oil-based and water-based components can be done with a high shear mixer to form an emulsion.
- the emulsion can be homogenized in a homogenizer, preferably at 3000-4000 psi.
- the resulting product can then be packaged or used in other applications as discussed below.
- a further aspect of the present invention is that emulsions of the invention have low microbial content even without being heat treated (i.e., pasteurized).
- pasteurization is typically conducted at high temperatures (about 180 F) for about 15 seconds.
- Other known heat treatments include VAT, HTST, UHT and retorting.
- Non-pasteurized compositions of the present invention have low microbial contents.
- emulsions of the present invention can have no detectable Pseudomonas or Salmonella.
- the emulsions can have a total bacteria count of ⁇ 20 Most Probable Number (“MPN”)/gram; a total Coliform and E.
- MPN Most Probable Number
- compositions of the invention can include an antimicrobial agent in an amount of between about 0.05 and about 0.1% w/w.
- additional functionally active ingredients e.g. flavors, pigments, sweeteners or antioxidants
- bioactive ingredients e.g. vitamins, minerals, pre-biotic compounds, pro-biotic compounds or other nutraceutical compounds
- additional functionally active ingredients can be incorporated in the emulsion. All such ingredients will be used following the recommendations of the manufacturer/supplier, as well as applicable governmental regulatory restrictions. These ingredients can be in either solid- powder or liquid form.
- additional functionally active ingredients can be incorporated in the emulsion or if the emulsion will be used in a food matrix, the additional ingredients can be added to the food matrix before addition of the emulsion to the food matrix.
- the additional functionally active ingredients When the additional functionally active ingredients are added first to the emulsion, they can be added to either the oil phase or the water phase (depending on whether they are more oil or water soluble), but are preferably added to the oil phase.
- the ingredients can be added with moderate agitation until fully dispersed in the phase being used.
- Some such additional ingredients, such as flavors and pigments, will complement flavors and colors in foods to which emulsions containing them are added.
- such additives can mask marine flavors contributed by the oils or emulsification agents.
- Flavors and pigments of all types can be included in emulsions of the invention with the exception of pigments containing iron as part of the molecule and flavors and pigments having low levels of metal contaminants, such as iron and copper.
- an LCPUFA emulsion is incorporated into liquid food products such as beverages (e.g., fruit juices and multivitamin syrups), into high moisture foods such as dairy products (e.g. yogurts), liquid pancake mixes and baby foods, into intermediate moisture foods such as health food bars and cheese, into processed meats (e.g. sausages), and as an ingredient in the preparation of baked goods (e.g., bread) or cereals.
- beverages e.g., fruit juices and multivitamin syrups
- high moisture foods such as dairy products (e.g. yogurts), liquid pancake mixes and baby foods
- intermediate moisture foods such as health food bars and cheese
- processed meats e.g. sausages
- baked goods e.g., bread
- An advantage of the emulsion of the present invention is that it can be uniformly dispersed in a wide variety of end products.
- Nanopure water 10 is mixed with citric acid, sodium citrate, sodium benzoate, and potassium sorbate 15 by gentle mixing 20 .
- Xanthan gum 25 is slowly added during the mixing process 20 .
- the resulting aqueous mixture is subjected to high shear mixing 26 in a Silverson mixer at 6,500 rpm for 3 minutes
- the oil component 30 and the emulsifier 35 either polysorbate 80 and/or lecithin are gently mixed 40 .
- the mixture of oil and emulsifier is then subjected to high shear mixing 45 in a Silverson mixer at 6,500 rpm for 3 minutes.
- the oil-based mixture from the high shear mixing 45 is added to the aqueous mixture from the high shear mixing 26 .
- the oil mixture and aqueous mixture are subjected to high shear mixing 50 at 6,500 rpm for 3 minutes.
- the resulting composition is processed in a homogenizer 55 at about 3,000 psi.
- the composition is then packaged in sterile containers 60 .
- This example illustrates the preparation of an emulsion of the present invention, and its stability over time and when used in a food application.
- DHA GOLDTM oil DHA-rich oil extracted from the marine microorganism Schizochytrium sp. was added to 25 grams of polysorbate 80 . The solution was heated to 60° C. for five minutes and mixed to dissolve the polysorbate. In a separate flask, 150 mg xanthan gum was mixed with 25 grams of water and vortexed. A new solution was made by taking 5 grams of the DHA GOLD oil/polysorbate solution and mixing with the entire 25+ grams of the water/xanthan gum solution. The new mixture was mixed and then heated at 60° C. for 1 minute to form the emulsion. The resulting mixture was stored in a refrigerator (4° C.) for 30 days. At the end of 30 days, no phase separation of the oil was observed. Odor evaluation of the emulsion indicated no formation of fishy odors—the emulsion was essentially odorless.
Abstract
Methods for making highly stable, oxidation-resistant emulsions comprising an oil, an emulsifier, an emulsion stabilizer and water are provided. The invention is particularly well suited for oils that are susceptible to oxidation, such as long chain polyunsaturated fatty acid oils. The resulting emulsion is highly stable and resistant to oxidation, and is useful in a number of products and as a stand-alone product.
Description
- The present invention is directed to oil-in-water emulsions, and in particular, emulsions that help protect oils from oxidation, especially oils that are susceptible to oxidation.
- It is desirable to form oil-in-water emulsions, and various techniques have been proposed to accomplish this task
- In the past, oil and polysorbate (or lecithin) and water have been combined to produce an emulsion, but the results have been unsatisfactory. The oil phase separated out of the mixture after relatively short periods of time and off-odors and off-tastes that developed indicated that oxidation products of the oil had formed. Oil and xanthan gum and water mixtures are only temporarily stable, like those found in salad dressings. Emulsification of oil can also be achieved through the addition of water to the oil, combined with strong, lengthy agitation, but the resulting emulsion is very unstable.
- Newer approaches have involved the use of proteins as emulsifiers. However, these emulsions are not stable over a wide range of pH conditions. For example, a protein that forms a stable emulsion under low pH conditions (e.g., pH 4) would denature at higher pH (e.g., pH 7), and would no longer act as an emulsifier. Another problem with protein emulsifiers is that upon heating, the protein is destabilized by its conformational change.
- The above-described techniques have failed because of the difficulty in maintaining the emulsification and the stability of the oils. The emulsification of the aqueous and oil phases is usually temporary, and the oil/water mixture typically reverts to separate aqueous and oil phases without continued agitation. When the oil is susceptible to oxidation, as is the case with long chain polyunsaturated fatty acids (LCPUFA), stability of the product is also diminished due to the more rapid oxidation of the oils, and in particular, the LCPUFA oils. Protein-based emulsions are not stable over the wide range of pH and temperature conditions found in foods.
- It would be advantageous to incorporate LCPUFA-containing oils in aqueous mixtures, such as aqueous food, cosmetic, pharmaceutical and industrial product matrices, without having the oil and water separate into two distinct phases. It would be advantageous to find ways to stabilize an oil-in-water emulsion over a long period of time, in other words, to form an emulsion that is physically stable (e.g., the oil and the water do not phase separate) for at least 30 days. It would be advantageous if the oil is protected by the emulsion from oxidation, in particular, when the oil is susceptible to oxidation, such as a LCPUFA oil.
- The present invention is directed toward an oil emulsion. The emulsion includes an oil component, an emulsifier, an emulsion stabilizer, and water. The oil component can include polyunsaturated fatty acids, such as polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons. Exemplary oil components include linolenic acid, stearidonic acid, arachidonic acid, eicosapentaenoic acid, docasapentaenoic acid, docosahexaenoic acid and mixtures thereof.
- The oil component can be an oil from plants, genetically modified plants, microbial oils, genetically modified microbial oils, fish oils and mixtures thereof. Such plants can include algae, flaxseeds, rapeseeds, corn, evening primrose, soy, sunflower, safflower, palm, olive, canola, borage, and mixtures thereof. When such plants are genetically modified, the genetic modifications can include the introduction or modification of polyketide synthase genes. The oil component can also include an oil from a microbial source such as Thraustochytriales, dinoflagellates, and fungal sources.
- In one embodiment, the emulsifier is selected from the group of polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, sodium lauryl sulfate and mixtures thereof In one embodiment, the emulsifier and the oil can be from the same source.
- In particular embodiments of the present invention, the stabilizer can be selected from the group of xanthan gum, alginate, gellan gum, carboxymethylcellulose, chitin and mixtures thereof.
- The weight ratio of the oil component to the emulsifier can be between about 1: 1 and about 99: 1, and is preferably about 6: 1. The ratio of water to emulsion stabilizer can be between about 1:0.1 and about 1:0.001. The ratio of oil component to water can be between about 2:1 and about 1:25.
- Oil emulsions of the present invention are highly stable and can be physically and/or chemically stable for at least about 30 days.
- The emulsion of the present invention can be an oil-in-water emulsion. Further, the emulsion can be produced without having been heat treated. The emulsion can also have a total bacteria count of less than 20MPN/gram. In other embodiments, the oil emulsion can include an antimicrobial component, such as propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid, citric acid and mixtures thereof.
- The emulsion of the present invention can also include functionally active ingredients, such as flavors, pigments, sweeteners and anti-oxidants. The emulsion can also include bioactive ingredients, such as vitamins, minerals, pre-biotic compounds, pro-biotic compounds and nutraceuticals.
- Other embodiments of the present invention include food products, cosmetic products, pharmaceutical products, nutriceutical products, and industrial products that include the oil emulsions of the invention.
- Alternative embodiments of the present invention include a method for forming an emulsion. The method includes combining an oil component, an emulsifier, an emulsion stabilizer and water. In one embodiment, the oil component and emusifier are combined; the emulsion stabilizer and the water are combined; and then, the oil component/emulsifier combination and the emulsion stabilizer/water combination are combined. The various components of the emulsion can be combined with high shear mixing.
- In a preferred embodiment of the present invention, an oil emulsion is provided. The emulsion includes an oil component that includes polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons. The emulsion further includes an emulsifier, an emulsion stabilizer, water and an antimicrobial component. In this embodiment, the weight ratio of oil component to emulsifier is between about 1:1 and about 99: 1. The ratio of water to emulsion stabilizer is between about 1:0.1 and about 1:0.001. The ratio of oil component to water is between about 2:1 and about 1:25. This oil emulsion composition is physically and chemically stable for at least about 30 days.
-
FIG. 1 is a flowsheet of an example of preparation of an emulsion of the present invention. - In accordance with one embodiment of the present invention, a method is provided for forming stable emulsions, particularly including LCPUFA. The method includes the step of mixing at least four ingredients: (1) oil; (2) emulsion stabilizer; (3) emulsifier; and (4) water. The resulting emulsion is an oil-in-water emulsion with water as the continuous phase. It is believed that the emulsion stabilizer assists in maintaining the long-term stability of the emulsion without the need to agitate the solution continually for even distribution, preventing the oxidation of the LCPUFA oils and maintaining the integrity of the oils, thereby enhancing a longer shelf life of the product.
- Preferably, the emulsion is stable for at least 30 days, and more preferably for at least 60 days. The resulting emulsions are very stable over a wide range of pH conditions and temperatures, and the LCPUFA oils are highly protected from oxidation. These emulsions can exist as stand-alone products and can easily be incorporated into a wide range of products, including food, personal care and industrial products (e.g., human foods, animal feeds, pharmaceuticals, nutraceuticals, cosmetics, industrial products, etc.). A particular advantage of the products of the present invention is that they can be uniformly dispersed in a wide variety of end products.
- The oil component of emulsions of the present invention can include any oil, preferably, any vegetable or microbial oil, including for example, oils having LCPUFA. Long chain PUFA oils can include any oil containing a fatty acid with at least two, and more preferably three or more double bonds, and a chain length of at least 18 carbons. Examples of LCPUFA oils include oils containing the fatty acids linolenic acid (18:3n-3), stearidonic acid (18:4n-3) arachidonic acid (20:4n-6), eicosapentaenoic acid (20:5n-3), docosapentaenoic acid (22:5n-3 and 22:5n-6) and docosahexaenoic acid (22:6n-3). Examples of these oils include oils from fish oils, microbial oils (e.g. from Thraustochytriales, such as Schizochytrium and Thraustochytrium, from dinoflagellates such as Ctypthecodinium, and from fungal sources such as Mortierella), plants, and oilseeds, as well as genetically modified fish oils, microbial oils, plants, and oilseeds.
- Sources of fatty acids (e.g., omega-3 and omega-6 LCPUFA) can include oils from animal, plant and microbial sources. As used herein, the term “oil” is used broadly to include fats and oils in various forms. The oil must be capable of emulsification. Preferred oils include triacylglycerol and ethyl ester forms of LCPUFA. Typically, the oils will be a mixture of different substances, such as triacylglycerols, ethyl esters, free fatty acids, phospholipids, sterols, etc. Such mixtures can be purified, if desired. Examples of animal sources include aquatic animals (e.g., fish, marine mammals, crustaceans, rotifers, etc.) and oils extracted from animal tissues (e.g., brain, liver, eyes, etc.). Examples of plant and microbial sources include algae, flaxseeds, rapeseeds, corn, evening primrose, soy, sunflower, safflower, palm, olive, canola and borage. A preferred source is aquatic algae such as algae of the order Thraustochytriales, and preferably algae of the genus Thraustochytrium and Schizochytrium. It should be noted that many experts agree that Ulkenia is not a separate genus from Thraustochytrium and Schizochytrium. As used herein, the genera Thraustochytrium and Schizochytrium will include Ulkenia. Information regarding such algae can be found in U.S. Pat. Nos. 5,130,242 and 5,340,594, which are incorporated herein by reference in their entirety. Another preferred source is the dinoflagellate of the genus Crypthecodinium. Information regarding Crypthecodinium can be found in U.S. Pat. Nos. 5,407,957; 5,711,983; 5,397,591; and 5,492,938, which are incorporated herein by reference in their entirety. Information regarding Mortierella can be found in U.S. Pat. Nos. 5,658,767 and 5,583,019, which are incorporated herein by reference in their entirety.
- Plant and microbial sources can include genetically modified plants and microorganisms, and preferably include genetic modified plants and microorganisms with increased or newly introduced production of PUFAs by the introduction or modification of a polyketide synthase system (PKS system). Information regarding genetic modifications involving PKS systems can be found in U.S. Patent No. 6,566,583, entitled “Schizochytrium PKS Genes” issued May 20, 3003; PCT Application No. U.S. Ser. No. 00/00956 entitled “Schizochytrium PKS Genes” filed Jan. 14, 2000; U.S. Pat. Application Ser. No. 10/124,807 entitled “Product and Process for Transformation of Thraustochytriales Microorganism” filed Apr. 16, 2002; PCT patent application No. PCT/US02/12040 entitled “Product and Process for Transformation of Thraustochytriales Microorganism” filed Apr. 16, 2002; U.S. patent application Ser. No. 10/124,800 entitled “PUFA Polyketide Synthase Systems and Uses Thereof” filed Apr. 16, 2002; and PCT Patent Application No. PCT/US02/12254 entitled “PUFA Polyketide Synthase Systems and Uses Thereof” filed Apr. 16, 2002; which are incorporated herein by reference in their entirety.
- Oils containing the desired fatty acids can be extracted from the various sources by any suitable means, such as by supercritical fluid extraction or by extraction with solvents such as chloroform, hexane, methylene chloride, methanol and the like. Alternatively, the oils can be extracted using extraction techniques, such as are described in U.S. patent application Ser. No. 09/766,500 and PCT Patent Application Serial No. US01/01806, both entitled “Solventless Extraction Process” and both filed Jan. 19, 2001, both of which are incorporated herein by reference in their entirety. Lecithins can be extracted by any suitable technique, and are obtainable from many of the same sources from which the oils can be obtained. In a preferred embodiment of the present invention, lecithin, which is useful as an emulsifier, and oil are obtained from the same source. The lecithin and oil may be extracted together, or separately extracted and remixed to form the emulsion. Additional extraction and/or purification techniques are taught in PCT Patent Application Serial No. US01/12047 entitled “Method for the Fractionation of Oil and Polar Lipid-Containing Native Raw Materials” filed Apr. 12, 2001; PCT Patent Application Serial No. US01/12849 entitled “Method for the Fractionation of Oil and Polar Lipid-Containing Native Raw Materials Using Water-Soluble Organic Solvent and Centrifugation” filed Apr. 12, 2001; U.S. Provisional Patent Application Serial No. 60/291,484 entitled “Production and Use of a Polar Lipid-Rich Fraction Containing Stearidonic Acid and Gamma Linolenic Acid from Plant Seeds and Microbes filed May 14, 2001; U.S. Provisional Patent Application Serial No. 60/290,899 entitled “Production and Use of a Polar-Lipid Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Patty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms” filed May 14, 2001; U.S. Pat. No. 6,399,803 entitled “Process for Separating a Triglyceride Comprising a Docosahexaenoic Acid Residue from a Mixture of Triglycerides” issued Jun. 4, 2002 filed Feb. 17, 2000; and PCT Patent Application Serial No. US01/01010 entitled “Process for Making an Enriched Mixture of Polyunsaturated Fatty Acid Esters” filed Jan. 11, 2001; all of which are incorporated herein by reference in their entirety. The extracted oils and lecithins can be evaporated under reduced pressure to produce a sample of concentrated oil material.
- In emulsions of the present invention, the oil is typically present in an amount from about 5 wt. % to about 50 wt. %, more preferably from about I0 wt. % to about 40 wt. %, and even more preferably from about 20 wt. % to about 30 wt. %.
- The emulsifier of emulsions of the present invention can include any emulsifier, including polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, and sodium lauryl sulfate. In a preferred embodiment of the present invention, a polysorbate ester (e.g., polyethylene sorbitan monooleate (Polysorbate 80), polyoxyethylene sorbitan monolaurate (Polysorbate 20), polyoxyethylene sorbitan tristearate (Polysorbate 65) or Polysorbate 60) is used as the emulsifier. In another preferred embodiment, the emulsifier can be a lecithin. Lecithins can be extracted from plant seeds, (e.g., soy lecithins), and can be extracted from eggs, milk, microbes or animal sources.
- In emulsions of the present invention, the emulsifier is typically present in an amount from about 1 wt. % to about 20 wt. %, more preferably from about 8 wt. % to about 15 wt. %, and even more preferably from about 2 wt % to about 6 wt. %.
- The emulsion stabilizer of the present invention functions to further stabilize the emulsion compared to the emulsion in the absence of the stabilizer. The stabilizer can also function as a thickener of the emulsion. The emulsion stabilizer can be selected from xanthan gum, alginate, gellan gum, carboxymethylcellulose and chitin. In a preferred embodiment of the present invention, xanthan gum is used as the stabilizer.
- In emulsions of the present invention, the emulsion stabilizer is typically present in an amount from about 10 wt. % to about 2 wt. %, more preferably from about 0.2 wt % to about 0.8 wt. %, and even more preferably from about 0.3 wt. % to about 0.5 wt. %.
- Emulsions of the present invention also include water. Water is typically present in an amount from about 80 wt. % to about 90 wt. %, more preferably from about 20 wt % to about 80 wt. %, and even more preferably from about 50 wt. % to about 70 wt. %.
- Emulsions of the present invention are highly stable in terms of both physical stability (i.e., lack of separation of components) and chemical stability (i.e., lack of oxidation of the oil component). Physical stability can be measured in a variety of ways. Simple visual observation of physical separation or “creaming” is an indication of separation. In preferred embodiments of the invention, no observable phase separation occurs after storage at 4 C, and more preferably after storage at room temperature (i.e., about 22 C), within 30 days, more preferably within 90 days, and more preferably within 180 days.
- Another measure of physical stability is a lack of change in the particle size of micelles formed in the emulsion. As emulsions separate, the size of micelles becomes greater. In preferred embodiments of the invention, the particle size of micelles will not increase more than about 15 %, more preferably not more than about 25 %, more preferably not more than about 30 %, more preferably not more than about 40 %, and more preferably not more than about 50 %, after storage at 4 C within 30 days, more preferably within 90 days, and more preferably within 180 days.
- Chemical stability of an emulsion can be measured in terms of oxidation of any of the species of the oil component, including linolenic acid, stearidonic acid, arachidonic acid, eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid. Oxidation can be measured by the production of secondary products of oxidation, such as by measuring peroxide values, anisidine values, or alkenal values or by conducting a headspace analysis. In preferred embodiments, for any one or more of these various measures of oxidation, the value of the measure after storage at room temperature (i.e., about 22 C) for 30 days will increase less than about 20% by 60 days and/or less than about 50% by 90 days.
- Another aspect of the physical and chemical stability of the invention is that the emulsions of the present invention can meet one or more of the physical or chemical stability parameters identified above over a wide range of pH conditions. More specifically, such parameters can be met over a pH range of about 3 to about 8, more preferably from about 3 to about 7, more preferably from about 3 to about 4.
- Another aspect of the physical and chemical stability of the invention is that the emulsions of the present invention can meet one or more of the physical or chemical stability parameters identified above over a wide range of temperature conditions. More specifically, such parameters can be met over a temperature range of up to about room temperature (i.e., about 22 C), emulsions will be most stable at refrigeration temperature of about 4 C.
- Emulsions of the present invention can be prepared by mixing the emulsifier with the oil in an initial step. Preferably, the weight ratio of oil to emulsifier is between about 1:1 and about 99:1, more preferably in a range from about 3:1 to about 50:1, more preferably in a range from about 4:1 to about 25:1, more preferably in a range from about 5:1 to about 10:1, more preferably in a ratio of about 6:1. Mixing can be facilitated by heating the mixture, for example, to about 60 C for about 5 minutes, but can also be mixed at room temperature.
- In an independent step of the process of preparing the emulsion, water and an emulsion stabilizer are mixed. Before this step, however, additional components that are water soluble, such as antimicrobial compounds like citric acid, sodium benzoate, and potassium sorbate, can be added to the water. A preferred weight ratio of water to emulsion stabilizer is in the range of about 1:0.1 to about 1:0.001, with a more preferred range of about 1:0.05 to about 1:0.005.
- The oil/emulsifier mixture and the water/emulsion stabilizer are then combined. Preferably, these two mixtures are combined to achieve an oil to water ratio of between about 2:1 to about 1:25. Typically, this combination can be made at room temperature for ease of preparation and to avoid unnecessary temperature stress on the oil. However, mild heating (e.g., 35 C to 40 C) can be used to facilitate combining the mixtures. Mixing of the oil-based and water-based components can be done with a high shear mixer to form an emulsion. At that point, the emulsion can be homogenized in a homogenizer, preferably at 3000-4000 psi. The resulting product can then be packaged or used in other applications as discussed below.
- A further aspect of the present invention is that emulsions of the invention have low microbial content even without being heat treated (i.e., pasteurized). For example, pasteurization is typically conducted at high temperatures (about 180 F) for about 15 seconds. Other known heat treatments include VAT, HTST, UHT and retorting. Non-pasteurized compositions of the present invention have low microbial contents. For example, emulsions of the present invention can have no detectable Pseudomonas or Salmonella. In addition, the emulsions can have a total bacteria count of <20 Most Probable Number (“MPN”)/gram; a total Coliform and E. coli count of <20 MPN/gram; a yeast and mold count of <20 MPN/gram; and/or a Staphylococcus aureus count of <10 Colony Forming Units (“CFU”)/gram. Low microbial content can be achieved by the inclusion of antimicrobial agents, such as propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid or citric acid in the composition. Such antimicrobial agents can be included in the composition in amounts up to the maximum allowable amount in food compositions. For example, compositions of the invention can include an antimicrobial agent in an amount of between about 0.05 and about 0.1% w/w.
- In a preferred embodiment of the present invention, additional functionally active ingredients (e.g. flavors, pigments, sweeteners or antioxidants) or bioactive ingredients (e.g. vitamins, minerals, pre-biotic compounds, pro-biotic compounds or other nutraceutical compounds) can be incorporated in the emulsion. All such ingredients will be used following the recommendations of the manufacturer/supplier, as well as applicable governmental regulatory restrictions. These ingredients can be in either solid- powder or liquid form. Such additional functionally active ingredients can be incorporated in the emulsion or if the emulsion will be used in a food matrix, the additional ingredients can be added to the food matrix before addition of the emulsion to the food matrix. When the additional functionally active ingredients are added first to the emulsion, they can be added to either the oil phase or the water phase (depending on whether they are more oil or water soluble), but are preferably added to the oil phase. The ingredients can be added with moderate agitation until fully dispersed in the phase being used. Some such additional ingredients, such as flavors and pigments, will complement flavors and colors in foods to which emulsions containing them are added. In addition, such additives can mask marine flavors contributed by the oils or emulsification agents.
- Flavors and pigments of all types can be included in emulsions of the invention with the exception of pigments containing iron as part of the molecule and flavors and pigments having low levels of metal contaminants, such as iron and copper.
- In a preferred embodiment of the present invention, an LCPUFA emulsion is incorporated into liquid food products such as beverages (e.g., fruit juices and multivitamin syrups), into high moisture foods such as dairy products (e.g. yogurts), liquid pancake mixes and baby foods, into intermediate moisture foods such as health food bars and cheese, into processed meats (e.g. sausages), and as an ingredient in the preparation of baked goods (e.g., bread) or cereals. The emulsion can also be used both functionally and as a source of LCPUFA in cosmetic and personal care applications and in industrial applications. An advantage of the emulsion of the present invention is that it can be uniformly dispersed in a wide variety of end products.
- With reference to
FIG. 1 , an example of preparation of an emulsion of the present invention is described. Nanopure water 10 is mixed with citric acid, sodium citrate, sodium benzoate, andpotassium sorbate 15 bygentle mixing 20.Xanthan gum 25 is slowly added during themixing process 20. The resulting aqueous mixture is subjected to high shear mixing 26 in a Silverson mixer at 6,500 rpm for 3 minutes Separately, theoil component 30 and theemulsifier 35, either polysorbate 80 and/or lecithin are gently mixed 40. The mixture of oil and emulsifier is then subjected to high shear mixing 45 in a Silverson mixer at 6,500 rpm for 3 minutes. The oil-based mixture from the high shear mixing 45 is added to the aqueous mixture from the high shear mixing 26. The oil mixture and aqueous mixture are subjected to high shear mixing 50 at 6,500 rpm for 3 minutes. The resulting composition is processed in ahomogenizer 55 at about 3,000 psi. The composition is then packaged insterile containers 60. - This application hereby incorporates by reference U.S. Provisional Application Serial No. 60/389,813, filed Jun. 18, 2002.
- The following experimental results are provided for the purposes of illustration and are not intended to limit the scope of the invention.
- This example illustrates the preparation of an emulsion of the present invention, and its stability over time and when used in a food application.
- A total of 75 grams of DHA-rich oil (DHA GOLD™ oil) extracted from the marine microorganism Schizochytrium sp. was added to 25 grams of polysorbate 80. The solution was heated to 60° C. for five minutes and mixed to dissolve the polysorbate. In a separate flask, 150 mg xanthan gum was mixed with 25 grams of water and vortexed. A new solution was made by taking 5 grams of the DHA GOLD oil/polysorbate solution and mixing with the entire 25+ grams of the water/xanthan gum solution. The new mixture was mixed and then heated at 60° C. for 1 minute to form the emulsion. The resulting mixture was stored in a refrigerator (4° C.) for 30 days. At the end of 30 days, no phase separation of the oil was observed. Odor evaluation of the emulsion indicated no formation of fishy odors—the emulsion was essentially odorless.
- To test the effects of the emulsified mixture, 16.8 grams of the emulsion formed above was added to 437 grams of liquid egg substitute product and mixed. The egg product was then cooked to produce scrambled eggs. The resulting mixture provided 99.12 mg/DHA per serving (serving size=56 g liquid). No difference could be detected in taste or odor between the cooked egg substitute containing the DHA-oil emulsion and cooked egg substitute without any DHA-oil emulsion.
- This example illustrates the composition of a lecithin based emulsion of the present invention in Table 1.
TABLE 1 Lecithin Based Emulsion Component Wt. Percent DHASCO-S ®*: DHA-containing oil 27.91 Polysorbate 80 0.30 Lecithin 4.63 Citric Acid Buffer (0.025M) 65.66 Xanthan Gum 0.43 Sodium Benzoate 0.05 Potassium Sorbate 0.05 TOTAL 100.00
*Registered trademark of Martek Biosciences Corporation
- This example illustrates the composition of a polysorbate based emulsion of the present invention in Table 2.
TABLE 2 Polysorbate Based Emulsion Component Wt. Percent DHASCO-S ®: DHA-containing oil 27.91 Polysorbate 80 4.92 Citric Acid Buffer (0.025M) 66.56 Xanthan Gum 0.43 Sodium Benzoate 0.05 Potassium Sorbate 0.05 TOTAL 100.00 - Those skilled in the art will appreciate that numerous changes and modifications may be made to the preferred embodiments of the invention and that such changes and modifications may be made without departing from the spirit of the invention. It is therefore intended that the appended claims cover all such equivalent variations as fall within the true spirit and scope of the invention.
Claims (68)
1-90. (canceled)
91. An oil emulsion, comprising:
an oil component comprising polyunsaturated fatty acids;
an emulsifier;
an emulsion stabilizer; and
water;
wherein the oil emulsion has not been heat treated.
92. The oil emulsion, as claimed in claim 91 , wherein the oil component comprises polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons.
93. The oil emulsion, as claimed in claim 91 , wherein the oil component comprises a fatty acid selected from the group consisting of linolenic acid, stearidonic acid, arachidonic acid, eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid and mixtures thereof.
94. The oil emulsion, as claimed in claim 91 , wherein the oil component comprises an oil from a source selected from the group consisting of plants, genetically modified plants, microbial oils, genetically modified microbial oils, fish oils and mixtures thereof.
95. The oil emulsion, as claimed in claim 94 , wherein the plants are selected from the group consisting of algae, flaxseeds, rapeseeds, corn, evening primrose, soy, sunflower, safflower, palm, olive, canola, borage and mixtures thereof.
96. The oil emulsion, as claimed in claim 94 , wherein the genetically modified plants and genetically modified microbial oils are genetically modified by the introduction or modification of polyketide synthase genes.
97. The oil emulsion, as claimed in claim 91 , wherein the oil component comprises an oil from a microbial source selected from the group consisting of Thraustochytriales, dinoflagellates, and fungal sources.
98. The oil emulsion, as claimed in claim 91 , wherein the emulsifier is selected from the group consisting of polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, and sodium lauryl sulfate and mixtures thereof.
99. The oil emulsion, as claimed in claim 91 , wherein the emulsifier is selected from the group consisting of polysorbate esters, lecithin and mixtures thereof.
100. The oil emulsion, as claimed in claim 91 , wherein the emulsifier and the oil are from the same source.
101. The oil emulsion, as claimed in claim 91 , wherein the stabilizer is selected from the group consisting of xanthan gum, alginate, gellan gum, carboxy methyl cellulose, chitin and mixtures thereof.
102. The oil emulsion, as claimed in claim 91 , further comprising an antimicrobial component.
103. The oil emulsion, as claimed in claim 102 , wherein the antimicrobial component is selected from the group consisting of propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid, citric acid and mixtures thereof.
104. The oil emulsion, as claimed in claim 91 , wherein the weight ratio of oil component to the emulsifier is between about 1:1 and about 99:1.
105. The oil emulsion, as claimed in claim 91 , wherein the weight ratio of oil component to the emulsifier is about 6:1.
106. The oil emulsion, as claimed in claim 91 , wherein the ratio of water to emulsion stabilizer is between about 1:0.1 to about 1:0.001.
107. The oil emulsion, as claimed in claim 91 , wherein the ratio of water to emulsion stabilizer is between about 1:0.05 to about 1:0.005.
108. The oil emulsion, as claimed in claim 91 , wherein the ratio of oil component to water is between about 2:1 to about 1:25.
109. The oil emulsion, as claimed in claim 91 , wherein the oil emulsion is physically stable for at least about 30 days.
110. The oil emulsion, as claimed in claim 109 , wherein the oil emulsion is physically stable for at least about 30 days at a pH range from about 3 to about 4.
111. The oil emulsion, as claimed in claim 109 , wherein the oil emulsion is physically stable for at least about 30 days at a temperature range of about 4 C.
112. The oil emulsion, as claimed in claim 91 , wherein the oil emulsion is chemically stable for at least about 30 days.
113. The oil emulsion, as claimed in claim 112 , wherein the oil emulsion is chemically stable for at least about 30 days at a pH range from about 3 to about 4.
114. The oil emulsion, as claimed in claim 112 , wherein the oil emulsion is chemically stable for at least about 30 days at a temperature range of about 4 C.
115. The oil emulsion, as claimed in claim 91 , wherein the emulsion is an oil-in-water emulsion.
116. The oil emulsion, as claimed in claim 91 , wherein oil emulsion has a total bacteria count of <20 MPN/gram.
117. The oil emulsion, as claimed in claim 91 , wherein the emulsion further comprises functionally active ingredients.
118. The oil emulsion, as claimed in claim 117 , wherein the functionally active ingredients are selected from the group consisting of flavors, pigments, sweeteners, and antioxidants.
119. The oil emulsion, as claimed in claim 91 , wherein the emulsion further comprises bioactive ingredients.
120. The oil emulsion, as claimed in claim 119 , wherein the bioactive ingredients are selected from the group consisting of vitamins, minerals, pre-biotic compounds, pro-biotic compounds and nutraceuticals.
121. The oil emulsion, as claimed in claim 91 , wherein the polyunsaturated fatty acids are from a marine microorganism, and wherein the oil emulsion has a pH of between about 3 to about 4.
122. A product selected from the group consisting of a food product, a cosmetic product, a pharmaceutical product, a nutraceutical product, and an industrial product, wherein the product comprises an oil emulsion comprising an oil component comprising polyunsaturated fatty acids; an emulsifier; an emulsion stabilizer; and water; wherein the oil emulsion has not been heat treated.
123. The product, as claimed in claim 122 , wherein the product is a food product selected from the group consisting of liquid food products and solid food products.
124. The food product, as claimed in claim 123 , wherein the food product is a liquid food product selected from the group consisting of beverages, energy drinks, infant formula, liquid meals, fruit juices, multivitamin syrups, meal replacers, medicinal foods, and infant syrups.
125. The food product, as claimed in claim 123 , wherein the food product is a solid food product selected from the group consisting of baby food, yogurt, cheese, cereal, pancake mixes, baked goods, food bars, processed meats, ice creams, frozen desserts, frozen yogurts, waffle mixes, and replacement egg mixes.
126. The product, as claimed in claim 122 , wherein the product is a cosmetic product.
127. The product, as claimed in claim 122 , wherein the product is a pharmaceutical product.
128. The product, as claimed in claim 122 , wherein the product is a nutraceutical product.
129. The product, as claimed in claim 122 , wherein the product is an industrial product.
130. A method of forming an emulsion, comprising combining an oil component comprising polyunsaturated fatty acids; an emulsifier; an emulsion stabilizer; and water; wherein the emulsion is not heat treated.
131. The method, as claimed in claim 130 , wherein the oil component and emulsifier are combined, the emulsion stabilizer and the water are combined; and the oil component/emulsifier combination and the emulsion stabilizer/water combination are combined.
132. The method, as claimed in claim 131 , wherein the oil component/emulsifier combination is made with high shear mixing and the combination of the oil component/emulsifier combination and the emulsion stabilizer/water combination is made with high shear mixing.
133. The method, as claimed in claim 130 , wherein the oil component comprises polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons.
134. The method, as claimed in claim 130 , wherein the oil component comprises a fatty acid selected from the group consisting of linolenic acid, stearidonic acid, arachidonic acid, eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid and mixtures thereof.
135. The method, as claimed in claim 130 , wherein the oil component comprises an oil from a microbial source selected from the group consisting of Thraustochytriales, dinoflagellates, and fungal sources.
136. The method, as claimed in claim 130 , wherein the emulsifier is selected from the group consisting of polysorbate esters, lecithin, monoglycerides, diglycerides, organic acid esters of monoglycerides, propylene glycol esters of fatty acids, polyglycerol esters of fatty acids, propylene glycol monostearate, sorbitan monostearate, sorbitan trioleate, and sodium lauryl sulfate.
137. The method, as claimed in claim 130 , wherein the emulsifier is selected from the group consisting of polysorbate esters, lecithin and mixtures thereof.
138. The method, as claimed in claim 130 , wherein the stabilizer is selected from the group consisting of xanthan gum, alginate, gellan gum, carboxy methyl cellulose, chitin and mixtures thereof.
139. The method, as claimed in claim 130 , further comprising an antimicrobial component.
140. The method, as claimed in claim 139 , wherein the antimicrobial component is selected from the group consisting of propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid, citric acid and mixtures thereof.
141. The method, as claimed in claim 130 , wherein the weight ratio of oil component to the emulsifier is about 6:1.
142. The method, as claimed in claim 130 , wherein the ratio of water to emulsion stabilizer is between about 1:0.05 to about 1:0.005.
143. The method, as claimed in claim 130 , wherein the ratio of oil component to water is between about 2:1 to about 1:25.
144. The method, as claimed in claim 130 , wherein the emulsion is physically stable for at least about 30 days.
145. The method, as claimed in claim 130 , wherein the emulsion is chemically stable for at least about 30 days.
146. The method, as claimed in claim 130 , wherein the emulsion is an oil-in-water emulsion.
147. The method, as claimed in claim 130 , wherein the emulsion has not been heat treated.
148. The method, as claimed in claim 130 , wherein the emulsion has a total bacteria count of <20 MPN/gram.
149. A process for preparing a product selected from the group consisting of a food product, a cosmetic product, a pharmaceutical product, a nutraceutical product, and an industrial product, wherein the process comprises the method as claimed in claim 130 .
150. An oil emulsion, comprising:
a. an oil component comprising polyunsaturated fatty acids having at least three double bonds and a chain length of at least 18 carbons; an emulsifier;
b. an emulsion stabilizer;
c. water; and
d. an antimicrobial component;
wherein the weight ratio of oil component to the emulsifier is between about 1:1 and about 99:1;
wherein the ratio of water to emulsion stabilizer is between about 1:0.1 to about 1:0.001;
wherein the ratio of oil component to water is between about 2:1 to about 1:25; and
wherein the oil emulsion is physically and chemically stable for at least about 30 days.
151. The oil emulsion, as claimed in claim 150 , wherein the oil component comprises an oil from a microbial source selected from the group consisting of Thraustochytriales, dinoflagellates, and fungal sources.
152. The oil emulsion, as claimed in claim 150 , wherein the emulsifier is selected from the group consisting of polysorbate esters, lecithins and mixtures thereof.
153. The oil emulsion, as claimed in claim 150 , wherein the stabilizer is selected from the group consisting of xanthan gum, alginate, gellan gum, carboxy methyl cellulose, chitin and mixtures thereof.
154. The oil emulsion, as claimed in claim 150 , wherein the antimicrobial component is selected from the group consisting of propylene glycol, potassium sorbate, sodium benzoate, ascorbic acid, phosphoric acid, citric acid and mixtures thereof.
155. The oil emulsion, as claimed in claim 150 , wherein the weight ratio of oil component to the emulsifier is about 6:1.
156. The oil emulsion, as claimed in claim 150 , wherein the ratio of water to emulsion stabilizer is between about 1:0.05 to about 1:0.005.
157. A product selected from the group consisting of a food product, a cosmetic product, a pharmaceutical product, a nutraceutical product, and an industrial product, wherein the product comprises the oil emulsion as claimed in claim 150.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/518,957 US20060165735A1 (en) | 2002-06-18 | 2003-06-18 | Stable emulsions of oils in aqueous solutions and methods for producing same |
US12/791,714 US8529979B2 (en) | 2002-06-18 | 2010-06-01 | Stable emulsions of oils in aqueous solutions and methods for producing same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38981302P | 2002-06-18 | 2002-06-18 | |
PCT/US2003/019108 WO2003105606A1 (en) | 2002-06-18 | 2003-06-18 | Stable emulsions of oils in aqueous solutions and methods for producing same |
US10/518,957 US20060165735A1 (en) | 2002-06-18 | 2003-06-18 | Stable emulsions of oils in aqueous solutions and methods for producing same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/791,714 Continuation US8529979B2 (en) | 2002-06-18 | 2010-06-01 | Stable emulsions of oils in aqueous solutions and methods for producing same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060165735A1 true US20060165735A1 (en) | 2006-07-27 |
Family
ID=29736678
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/518,957 Abandoned US20060165735A1 (en) | 2002-06-18 | 2003-06-18 | Stable emulsions of oils in aqueous solutions and methods for producing same |
US12/791,714 Expired - Lifetime US8529979B2 (en) | 2002-06-18 | 2010-06-01 | Stable emulsions of oils in aqueous solutions and methods for producing same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/791,714 Expired - Lifetime US8529979B2 (en) | 2002-06-18 | 2010-06-01 | Stable emulsions of oils in aqueous solutions and methods for producing same |
Country Status (6)
Country | Link |
---|---|
US (2) | US20060165735A1 (en) |
EP (2) | EP2368445A1 (en) |
JP (3) | JP2005529728A (en) |
AU (2) | AU2003238264B2 (en) |
CA (1) | CA2489391A1 (en) |
WO (1) | WO2003105606A1 (en) |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060211776A1 (en) * | 2005-03-16 | 2006-09-21 | Baker Hughes Incorporated | Compositions and use of mono-and polyenoic acids for breaking VES-gelled fluids |
US20080058418A1 (en) * | 2006-09-06 | 2008-03-06 | The Coca-Cola Company | Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion |
US20080152725A1 (en) * | 2002-12-10 | 2008-06-26 | Everett Laboratories, Inc. | Methods and kits for co-administration of nutritional supplements |
US20090018186A1 (en) * | 2006-09-06 | 2009-01-15 | The Coca-Cola Company | Stable beverage products comprising polyunsaturated fatty acid emulsions |
US20090297491A1 (en) * | 2008-03-20 | 2009-12-03 | Bromley Philip J | Compositions containing non-polar compounds |
US20090297665A1 (en) * | 2008-03-20 | 2009-12-03 | Bromley Philip J | Compositions containing non-polar compounds |
US20090317532A1 (en) * | 2008-06-23 | 2009-12-24 | Bromley Philip J | Compositions containing non-polar compounds |
US20110236364A1 (en) * | 2010-03-23 | 2011-09-29 | Bromley Philip J | Compositions containing non-polar compounds |
US8101587B2 (en) | 2004-08-12 | 2012-01-24 | Everett Laboratories, Inc. | Kits for nutrition supplementation |
US20120093998A1 (en) * | 2009-02-11 | 2012-04-19 | Karl Manfred Voelker | High concentrated pufa emulsions |
US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
DE102011116390A1 (en) * | 2011-10-20 | 2013-04-25 | Macinwood Engineering Gesellschaft Für Die Holzindustrie Mbh | A method of providing a waxy water-based emulsion for producing a wood-containing structure |
US8741373B2 (en) * | 2010-06-21 | 2014-06-03 | Virun, Inc. | Compositions containing non-polar compounds |
US9132291B2 (en) | 2010-10-05 | 2015-09-15 | Dfb Technology, Ltd. | Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa |
US9302017B2 (en) | 2012-03-30 | 2016-04-05 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
US9351517B2 (en) | 2013-03-15 | 2016-05-31 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and compositions containing same |
US9480651B2 (en) | 2012-03-30 | 2016-11-01 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms |
US9693574B2 (en) | 2013-08-08 | 2017-07-04 | Virun, Inc. | Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch |
US9717703B2 (en) | 2009-10-16 | 2017-08-01 | Glaxosmithkline Llc | Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed |
US9861611B2 (en) | 2014-09-18 | 2018-01-09 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same |
US10016363B2 (en) | 2014-09-18 | 2018-07-10 | Virun, Inc. | Pre-spray emulsions and powders containing non-polar compounds |
US20190014808A1 (en) * | 2016-04-14 | 2019-01-17 | Clover Corporation Limited | Methods of manufacturing nutritional formulations |
US10287528B2 (en) | 2012-03-30 | 2019-05-14 | Micelle Biopharma, Inc. | Omega-3 fatty acid ester compositions |
US20200325342A1 (en) * | 2019-04-12 | 2020-10-15 | Viavi Solutions Inc. | Method for manufacturing a special effect pigment using an emulsion |
US10874122B2 (en) | 2012-02-10 | 2020-12-29 | Virun, Inc. | Beverage compositions containing non-polar compounds |
US10894027B2 (en) | 2012-03-30 | 2021-01-19 | Micelle Biopharma, Inc. | Sickle cell disease treatment utilizing omega-3 fatty acids |
US20210277320A1 (en) * | 2018-07-02 | 2021-09-09 | Innospec Limited | Compositions, Uses and Methods for Improving The Low Temperature Properties of a Middle Distillate Fuel |
US11382980B2 (en) * | 2013-10-08 | 2022-07-12 | Taiyo Kagaku Co., Ltd. | Oil/fat composition containing polyunsaturated fatty acid |
US11571379B2 (en) * | 2020-01-24 | 2023-02-07 | The Procter & Gamble Company | Skin care composition |
WO2023146984A1 (en) * | 2022-01-26 | 2023-08-03 | Amarin Pharmaceuticals Ireland Limited | Lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6974592B2 (en) | 2002-04-11 | 2005-12-13 | Ocean Nutrition Canada Limited | Encapsulated agglomeration of microcapsules and method for the preparation thereof |
ES2347045T3 (en) | 2002-11-04 | 2010-10-25 | Ocean Nutrition Canada Limited | MICROCAPSULES THAT HAVE MULTIPLE CORTEZAS, AND METHOD FOR THEIR PREPARATION. |
US20050074469A1 (en) * | 2003-10-03 | 2005-04-07 | Charles Signorino | Stable lipophilic emulsions for acrylic coating and method of making |
NO322041B1 (en) * | 2004-10-22 | 2006-08-07 | Pharmalogica As | Nutritional supplement containing fish oil and milk solids as emulsifier and process for preparation. |
WO2007067207A1 (en) * | 2005-05-11 | 2007-06-14 | Advanced Bionutrition Corporation | Stabilized form of fish oil |
CA2624616A1 (en) | 2005-05-12 | 2006-11-23 | Martek Biosciences Corporation | Biomass hydrolysate and uses and production thereof |
NO323665B1 (en) * | 2005-06-27 | 2007-06-18 | Pharmalogica As | Drink comprehensive fish oil and probiotic bacteria and preparation methods. |
WO2007005727A2 (en) | 2005-07-01 | 2007-01-11 | Martek Biosciences Corporation | Microwaveable popcorn and methods of making |
CN101252844A (en) * | 2005-07-01 | 2008-08-27 | 马泰克生物科学公司 | Polyunsaturated fatty acid-containing oil product and uses and production thereof |
CA2614095A1 (en) * | 2005-07-01 | 2007-01-11 | Martek Biosciences Corporation | Polyunsaturated fatty acid-containing oil product and uses and production thereof |
US9968120B2 (en) | 2006-05-17 | 2018-05-15 | Dsm Nutritional Products Ag | Homogenized formulations containing microcapsules and methods of making and using thereof |
US20100055281A1 (en) | 2006-04-07 | 2010-03-04 | Ocean Nutrition Canada Limited | Emulsions and Microcapsules With Substances Having Low Interfacial Tension, Methods of Making and Using Thereof |
CN101466270A (en) * | 2006-04-11 | 2009-06-24 | 马泰克生物科学公司 | Food products comprising long chain polyunsaturated fatty acids and methods for preparing the same |
MX306461B (en) | 2006-06-05 | 2013-01-07 | Ocean Nutrition Canada Ltd | Microcapsules with improved shells |
US20070299133A1 (en) * | 2006-06-23 | 2007-12-27 | Haile Mehansho | Concentrated omega-3 fatty acids and mixtures containing them |
WO2008022131A1 (en) * | 2006-08-14 | 2008-02-21 | Martek Biosciences Corporation | Enriched beverages and methods of making the same |
EP2124905B1 (en) | 2007-01-10 | 2016-09-07 | DSM Nutritional Products AG | Microcapsules including pea protein |
AU2008269989B2 (en) * | 2007-06-29 | 2014-02-27 | Dsm Ip Assets B.V. | Production and purification of esters of polyunsaturated fatty acids |
JP5610187B2 (en) * | 2007-09-04 | 2014-10-22 | 国立大学法人東京海洋大学 | Antioxidant |
AU2008331562B2 (en) | 2007-11-29 | 2013-11-14 | Monsanto Technology Llc | Meat products with increased levels of beneficial fatty acids |
NO20081487L (en) | 2008-03-27 | 2009-09-28 | Smartfish As | Health promoting drink |
GB0814105D0 (en) | 2008-08-01 | 2008-09-10 | Springdale Sustainable Develop | Composition for accelerated production of collagen |
JP5288407B2 (en) * | 2008-12-22 | 2013-09-11 | 長谷川香料株式会社 | O / W emulsified composition of oil-soluble substance |
CA2760990A1 (en) * | 2009-06-30 | 2011-01-06 | Solae, Llc | Omega-3 fatty acid enriched baked foods and bar compositions |
CA2761010A1 (en) * | 2009-06-30 | 2011-01-06 | Solae, Llc | Omega-3 fatty acid enriched beverages |
FR2949059B1 (en) * | 2009-08-11 | 2012-12-28 | Raphael Colicci | PROCESS FOR THE PREPARATION OF AN INTEGRAL JUICE OF OLIVE, COMPOSITION OBTAINED ACCORDING TO SAID METHOD AND ITS APPLICATION IN THE FIELD OF COSMETICS AND DIETETICS |
ITBS20100017A1 (en) * | 2010-02-03 | 2011-08-04 | Francesco Palladini | PROCEDURE FOR THE PRODUCTION OF A FOOD AND SUPPLEMENTARY SUPPLEMENTER SO OBTAINED |
US8318233B2 (en) * | 2010-03-26 | 2012-11-27 | Corn Products Development Inc | Emulsions useful in beverages |
BR112012029418A2 (en) * | 2010-05-20 | 2017-02-21 | Hyun Jung Chung | Outdoor skin preparation composition with excellent antibacterial and antifungal effects |
US20120135104A1 (en) * | 2010-11-30 | 2012-05-31 | Bhiku Patel | Enhanced Absorption of Omega Fatty Acid Oils |
US20120251685A1 (en) * | 2011-04-04 | 2012-10-04 | Martek Biosciences Corporation | Oil-in-Water Emulsions Comprising a Polyunsaturated Fatty Acid and Methods of Making the Same |
SG11201401783YA (en) | 2011-11-01 | 2014-05-29 | Dsm Ip Assets Bv | Oxidatively stable polyunsaturated fatty acid containing oil |
CN103416759A (en) * | 2012-05-24 | 2013-12-04 | 内蒙古蒙牛乳业(集团)股份有限公司 | DHA emulsion, preparation method thereof and applications thereof in UHT liquid milk |
BR112016010688B1 (en) | 2013-11-13 | 2021-09-08 | Fuji Oil Holdings Inc | METHODS TO PRODUCE AN EDIBLE VEGETABLE FAT CONTAINING POLYUNSATURATED FATTY ACID, TO SUPPRESS THE GENERATION OF AROMA INGREDIENTS IN A FOOD AND TO PRODUCE A FAT CONTAINING HIGHLY POLY-INSATURATED FATTY ACID FOR DISTRIBUTION IN A LIQUID FORM |
ES2607715B1 (en) * | 2015-10-01 | 2018-01-17 | Solutex Na, Lcc | PROCESS FOR THE PREPARATION AND STABILIZATION OF EMULSIONS WITH OMEGA-3 THROUGH ISOMETRIC CRYSTAL NETWORKS OF CELLULOSE DERIVATIVES |
AR105674A1 (en) * | 2016-08-11 | 2017-10-25 | Consejo Nac De Investigaciones Científicas Y Técnicas (Conicet) | AN EDIBLE NANOEMULSION OF CHIA'S OIL |
WO2018108976A1 (en) * | 2016-12-13 | 2018-06-21 | Dsm Ip Assets B.V. | Pufa salt formulations (ii) |
CN110785161B (en) | 2017-06-23 | 2023-06-20 | 宝洁公司 | Compositions and methods for improving the appearance of skin |
EP3681294A1 (en) * | 2017-09-12 | 2020-07-22 | PURAC Biochem BV | Meat treatment |
KR20210011964A (en) | 2018-07-03 | 2021-02-02 | 더 프록터 앤드 갬블 캄파니 | How to treat a skin condition |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
JP2023528616A (en) | 2020-06-01 | 2023-07-05 | ザ プロクター アンド ギャンブル カンパニー | Method for improving skin penetration of vitamin B3 compounds |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4637937A (en) * | 1984-07-23 | 1987-01-20 | Asahi Denka Kogyo Kabushiki Kaisha | Process for making creamy bacteria-free foamable oil-in-water emulsion including chocolate |
US5156875A (en) * | 1991-06-17 | 1992-10-20 | Doyle W. Boatwright | Stabilized antimicrobial food composition |
US5258194A (en) * | 1990-11-02 | 1993-11-02 | Pfizer Inc. | Process for preparing a browning composition |
US5302408A (en) * | 1987-02-18 | 1994-04-12 | Van Den Bergh Foods Co., Division Of Conopco Inc. | Edible plastified dispersion |
US5324445A (en) * | 1988-08-24 | 1994-06-28 | Allied Colloids Limited | Polymeric compositions |
US5550156A (en) * | 1991-01-24 | 1996-08-27 | Martek Corporation | Microbial oil mixtures and uses thereof |
US5658767A (en) * | 1991-01-24 | 1997-08-19 | Martek Corporation | Arachidonic acid and methods for the production and use thereof |
US6034130A (en) * | 1997-07-22 | 2000-03-07 | Nestec S.A. | Lipid composition for infant formula and method of preparation |
US6140374A (en) * | 1998-10-23 | 2000-10-31 | Abbott Laboratories | Propofol composition |
US6190721B1 (en) * | 1997-12-03 | 2001-02-20 | Snow Brand Milk Products Co., Ltd. | Spread |
US6231915B1 (en) * | 1997-08-22 | 2001-05-15 | Lipton, Division Of Conopco, Inc. | Stanol comprising compositions |
US6348610B1 (en) * | 1999-06-04 | 2002-02-19 | Consejo Superior De Investigaciones Cientificas (Csic) | Oil from seeds with a modified fatty acid composition |
US6410078B1 (en) * | 1995-04-28 | 2002-06-25 | Loders-Croklaan B.V. | Triglycerides, rich in polyunsaturated fatty acids |
US6423363B1 (en) * | 1997-08-22 | 2002-07-23 | Lipton, Division Of Conopco, Inc. | Aqueous dispersion |
US20020182303A1 (en) * | 2001-03-30 | 2002-12-05 | Ajinomoto Co., Inc. | Oil-in-water type emulsion food |
US20020197382A1 (en) * | 2001-05-03 | 2002-12-26 | Unilever Bestfoods North America, Division Of Conopco, Inc. | Edible oil-in-water emulsion having a reduced content of oil |
US6716460B2 (en) * | 2001-05-14 | 2004-04-06 | Martek Biosciences Corporation | Method of improving the flavor, tenderness and overall consumer acceptability of poultry meat |
US6737084B2 (en) * | 2000-06-27 | 2004-05-18 | Qualilife | Compositions and methods for enhancing or treating female sexual response |
US6793958B2 (en) * | 2000-10-27 | 2004-09-21 | Lipton, Division Of Conopco, Inc. | Emulsified food composition |
US20050129739A1 (en) * | 2001-05-14 | 2005-06-16 | Gerhard Kohn | Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms |
US7029719B1 (en) * | 2000-07-10 | 2006-04-18 | Tajimaya Foods Co., Ltd. | Mayonnaise-like food and method of manufacturing the same |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6016573A (en) * | 1983-07-07 | 1985-01-28 | Lion Corp | Emulsified liquid dressing |
JPS60118164A (en) * | 1983-11-30 | 1985-06-25 | Sakamoto Yakuhin Kogyo Kk | Acidic o/w-type emulsion composition |
US4913921A (en) | 1987-09-11 | 1990-04-03 | General Mills, Inc. | Food products containing fish oils stabilized with fructose |
US5340594A (en) * | 1988-09-07 | 1994-08-23 | Omegatech Inc. | Food product having high concentrations of omega-3 highly unsaturated fatty acids |
US5130242A (en) * | 1988-09-07 | 1992-07-14 | Phycotech, Inc. | Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
US5080921A (en) * | 1990-02-05 | 1992-01-14 | Pfizer Inc. | Low calorie fat substitute |
US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
JP2947656B2 (en) | 1991-11-26 | 1999-09-13 | 花王株式会社 | Emulsified fat composition |
JPH05199837A (en) * | 1992-01-24 | 1993-08-10 | Nippon Oil & Fats Co Ltd | O/w-type emulsion composition |
JP3231075B2 (en) * | 1992-04-03 | 2001-11-19 | 株式会社コーセー | Cosmetic for preventing skin aging |
JP3197938B2 (en) * | 1992-04-03 | 2001-08-13 | 株式会社コーセー | Cosmetic for preventing skin aging |
JP2787884B2 (en) * | 1993-01-14 | 1998-08-20 | 雪印乳業株式会社 | Oil-in-water emulsified fat composition |
KR100343664B1 (en) * | 1993-12-20 | 2002-11-27 | 산에이겐 에후.에후. 아이. 가부시키가이샤 | Stable emulsified compositions and foods containing the same |
JP3438745B2 (en) | 1994-03-31 | 2003-08-18 | 日本油脂株式会社 | DHA-containing multi-phase emulsion type fat composition |
US5583019A (en) | 1995-01-24 | 1996-12-10 | Omegatech Inc. | Method for production of arachidonic acid |
JP3016704B2 (en) * | 1995-02-07 | 2000-03-06 | 賢一 最上 | Process for producing oil-in-water food additive containing marine animal fats and oils |
JP2922458B2 (en) | 1996-02-28 | 1999-07-26 | 日清製油株式会社 | Seasoning for stir-fry |
DE19644518A1 (en) | 1996-10-25 | 1998-04-30 | Nutricia Nv | Aqueous fat emulsion for use in enteral nutrition |
JPH10290929A (en) * | 1997-02-21 | 1998-11-04 | Lion Corp | Production of o/w type emulsion |
JP4128245B2 (en) * | 1997-05-02 | 2008-07-30 | 日清オイリオグループ株式会社 | Emulsification stabilizer |
US6140486A (en) * | 1997-06-04 | 2000-10-31 | Calgene Llc | Production of polyunsaturated fatty acids by expression of polyketide-like synthesis genes in plants |
US6566583B1 (en) | 1997-06-04 | 2003-05-20 | Daniel Facciotti | Schizochytrium PKS genes |
JP4761093B2 (en) | 1997-12-10 | 2011-08-31 | シクロスポリン セラポイティクス リミテッド | Pharmaceutical composition comprising omega-3 fatty acid oil |
DE19756123A1 (en) * | 1997-12-17 | 1999-06-24 | Remedia Pharmazeutische Praepa | Oral compositions containing unsaturated fatty acids, e.g. fish oils |
US6132793A (en) * | 1998-06-12 | 2000-10-17 | Olivia Gourmet Ltd. | Method of manufacturing a butterlike composition |
JP4709380B2 (en) | 1998-06-17 | 2011-06-22 | ディーエスエム アイピー アセッツ ビー.ブイ. | Microbial arachidonic acid (ARA) for marine feed |
US6399803B1 (en) | 1999-02-26 | 2002-06-04 | Omegatech, Inc. | Process for separating a triglyceride comprising a docosahexaenoic acid residue from a mixture of triglycerides |
EP1177728A4 (en) * | 1999-04-16 | 2003-03-19 | San Ei Gen Ffi Inc | Sucralose-containing composition and eatable product comprising the same |
GB9918023D0 (en) * | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
AU2634101A (en) * | 2000-01-06 | 2001-07-16 | Martek Biosciences Corporation | Therapeutic preparations of highly unsaturated fatty acids |
JP2001192328A (en) * | 2000-01-11 | 2001-07-17 | Nof Corp | Emulsified cosmetic |
DE10013156A1 (en) * | 2000-03-17 | 2001-09-20 | Volkhard Jenning | Water-containing vehicle for cosmetic or dermatological compositions, in which active agents or auxiliaries are stabilized by combination of ascorbic acid or derivative, polyphenol and buffer |
SE523211C2 (en) | 2000-04-26 | 2004-04-06 | Skaanemejerier Ekonomisk Foere | Lipid composition comprising a protective oil and a polyunsaturated fatty acid, emulsion containing such a composition and process for preparing the emulsion |
JP4031219B2 (en) * | 2000-08-08 | 2008-01-09 | 花王株式会社 | Oil composition |
WO2002011550A2 (en) | 2000-08-08 | 2002-02-14 | Kao Corporation | Oil/fat composition |
JP3403703B2 (en) * | 2000-08-09 | 2003-05-06 | 佳津良 足立 | Method for producing emulsified and dispersed composition and emulsified and dispersed composition obtained by the method |
GB0119583D0 (en) * | 2001-08-10 | 2001-10-03 | Unilever Plc | Cosmetic composition and method of treating skin |
JP5118284B2 (en) * | 2002-01-25 | 2013-01-16 | 花王株式会社 | Oil-in-water emulsion composition |
-
2003
- 2003-06-18 AU AU2003238264A patent/AU2003238264B2/en not_active Ceased
- 2003-06-18 EP EP11171163A patent/EP2368445A1/en not_active Withdrawn
- 2003-06-18 CA CA002489391A patent/CA2489391A1/en not_active Abandoned
- 2003-06-18 WO PCT/US2003/019108 patent/WO2003105606A1/en active Application Filing
- 2003-06-18 EP EP03737159A patent/EP1531687A4/en not_active Ceased
- 2003-06-18 JP JP2004512524A patent/JP2005529728A/en not_active Withdrawn
- 2003-06-18 US US10/518,957 patent/US20060165735A1/en not_active Abandoned
-
2006
- 2006-05-25 JP JP2006144750A patent/JP4913477B2/en not_active Expired - Fee Related
-
2009
- 2009-08-04 AU AU2009203200A patent/AU2009203200A1/en not_active Abandoned
-
2010
- 2010-06-01 US US12/791,714 patent/US8529979B2/en not_active Expired - Lifetime
-
2011
- 2011-07-04 JP JP2011147864A patent/JP2011255373A/en active Pending
Patent Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4637937A (en) * | 1984-07-23 | 1987-01-20 | Asahi Denka Kogyo Kabushiki Kaisha | Process for making creamy bacteria-free foamable oil-in-water emulsion including chocolate |
US5302408A (en) * | 1987-02-18 | 1994-04-12 | Van Den Bergh Foods Co., Division Of Conopco Inc. | Edible plastified dispersion |
US5324445A (en) * | 1988-08-24 | 1994-06-28 | Allied Colloids Limited | Polymeric compositions |
US5258194A (en) * | 1990-11-02 | 1993-11-02 | Pfizer Inc. | Process for preparing a browning composition |
US5550156A (en) * | 1991-01-24 | 1996-08-27 | Martek Corporation | Microbial oil mixtures and uses thereof |
US5658767A (en) * | 1991-01-24 | 1997-08-19 | Martek Corporation | Arachidonic acid and methods for the production and use thereof |
US5156875A (en) * | 1991-06-17 | 1992-10-20 | Doyle W. Boatwright | Stabilized antimicrobial food composition |
US20020081366A1 (en) * | 1995-04-28 | 2002-06-27 | Cain Frederick William | Triglycerides, rich in polyunsaturated fatty acids |
US6410078B1 (en) * | 1995-04-28 | 2002-06-25 | Loders-Croklaan B.V. | Triglycerides, rich in polyunsaturated fatty acids |
US6034130A (en) * | 1997-07-22 | 2000-03-07 | Nestec S.A. | Lipid composition for infant formula and method of preparation |
US6231915B1 (en) * | 1997-08-22 | 2001-05-15 | Lipton, Division Of Conopco, Inc. | Stanol comprising compositions |
US6423363B1 (en) * | 1997-08-22 | 2002-07-23 | Lipton, Division Of Conopco, Inc. | Aqueous dispersion |
US6190721B1 (en) * | 1997-12-03 | 2001-02-20 | Snow Brand Milk Products Co., Ltd. | Spread |
US6140374A (en) * | 1998-10-23 | 2000-10-31 | Abbott Laboratories | Propofol composition |
US6348610B1 (en) * | 1999-06-04 | 2002-02-19 | Consejo Superior De Investigaciones Cientificas (Csic) | Oil from seeds with a modified fatty acid composition |
US6737084B2 (en) * | 2000-06-27 | 2004-05-18 | Qualilife | Compositions and methods for enhancing or treating female sexual response |
US7029719B1 (en) * | 2000-07-10 | 2006-04-18 | Tajimaya Foods Co., Ltd. | Mayonnaise-like food and method of manufacturing the same |
US6793958B2 (en) * | 2000-10-27 | 2004-09-21 | Lipton, Division Of Conopco, Inc. | Emulsified food composition |
US20020182303A1 (en) * | 2001-03-30 | 2002-12-05 | Ajinomoto Co., Inc. | Oil-in-water type emulsion food |
US20020197382A1 (en) * | 2001-05-03 | 2002-12-26 | Unilever Bestfoods North America, Division Of Conopco, Inc. | Edible oil-in-water emulsion having a reduced content of oil |
US6716460B2 (en) * | 2001-05-14 | 2004-04-06 | Martek Biosciences Corporation | Method of improving the flavor, tenderness and overall consumer acceptability of poultry meat |
US20050129739A1 (en) * | 2001-05-14 | 2005-06-16 | Gerhard Kohn | Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms |
Cited By (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080152725A1 (en) * | 2002-12-10 | 2008-06-26 | Everett Laboratories, Inc. | Methods and kits for co-administration of nutritional supplements |
US8617617B2 (en) | 2002-12-10 | 2013-12-31 | Everett Laboratories, Inc. | Methods and kits for co-administration of nutritional supplements |
US8101587B2 (en) | 2004-08-12 | 2012-01-24 | Everett Laboratories, Inc. | Kits for nutrition supplementation |
US10265343B2 (en) | 2004-08-12 | 2019-04-23 | Exeltis Usa, Inc. | Kits and methods for nutrition supplementation |
US8609629B2 (en) | 2004-08-12 | 2013-12-17 | Evertt Laboratories, Inc. | Kits and methods for nutrition supplementation |
US20060211776A1 (en) * | 2005-03-16 | 2006-09-21 | Baker Hughes Incorporated | Compositions and use of mono-and polyenoic acids for breaking VES-gelled fluids |
US7645724B2 (en) * | 2005-03-16 | 2010-01-12 | Baker Hughes Incorporated | Compositions and use of mono- and polyenoic acids for breaking VES-gelled fluids |
US20080058418A1 (en) * | 2006-09-06 | 2008-03-06 | The Coca-Cola Company | Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion |
US20090018186A1 (en) * | 2006-09-06 | 2009-01-15 | The Coca-Cola Company | Stable beverage products comprising polyunsaturated fatty acid emulsions |
US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
US10220007B2 (en) | 2008-03-20 | 2019-03-05 | Virun, Inc. | Compositions containing non-polar compounds |
US20090297665A1 (en) * | 2008-03-20 | 2009-12-03 | Bromley Philip J | Compositions containing non-polar compounds |
US8765661B2 (en) | 2008-03-20 | 2014-07-01 | Virun, Inc. | Compositions containing non-polar compounds |
US9788564B2 (en) | 2008-03-20 | 2017-10-17 | Virun, Inc. | Compositions containing non-polar compounds |
US8282977B2 (en) | 2008-03-20 | 2012-10-09 | Virun, Inc. | Compositions containing non-polar compounds |
US20090297491A1 (en) * | 2008-03-20 | 2009-12-03 | Bromley Philip J | Compositions containing non-polar compounds |
US10668029B2 (en) | 2008-03-20 | 2020-06-02 | Virun, Inc. | Compositions containing non-polar compounds |
US20090317532A1 (en) * | 2008-06-23 | 2009-12-24 | Bromley Philip J | Compositions containing non-polar compounds |
CN102131407A (en) * | 2008-06-23 | 2011-07-20 | 维尔恩公司 | Compositions containing nono-polar compounds |
US8337931B2 (en) | 2008-06-23 | 2012-12-25 | Virun, Inc. | Compositions containing non-polar compounds |
KR101805200B1 (en) * | 2009-02-11 | 2017-12-05 | 디에스엠 아이피 어셋츠 비.브이. | High concentrated pufa emulsions |
US20120093998A1 (en) * | 2009-02-11 | 2012-04-19 | Karl Manfred Voelker | High concentrated pufa emulsions |
US9717703B2 (en) | 2009-10-16 | 2017-08-01 | Glaxosmithkline Llc | Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed |
US10668038B2 (en) | 2009-10-16 | 2020-06-02 | Mochida Pharmaceutical Co., Ltd. | Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed |
US20110236364A1 (en) * | 2010-03-23 | 2011-09-29 | Bromley Philip J | Compositions containing non-polar compounds |
US9320295B2 (en) | 2010-03-23 | 2016-04-26 | Virun, Inc. | Compositions containing non-polar compounds |
US10335385B2 (en) * | 2010-06-21 | 2019-07-02 | Virun, Inc. | Composition containing non-polar compounds |
US20140227242A1 (en) * | 2010-06-21 | 2014-08-14 | Philip J. Bromley | Compositions containing non-polar compounds |
US8741373B2 (en) * | 2010-06-21 | 2014-06-03 | Virun, Inc. | Compositions containing non-polar compounds |
US9132291B2 (en) | 2010-10-05 | 2015-09-15 | Dfb Technology, Ltd. | Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa |
US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
US8545896B2 (en) | 2011-09-29 | 2013-10-01 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
DE102011116390A1 (en) * | 2011-10-20 | 2013-04-25 | Macinwood Engineering Gesellschaft Für Die Holzindustrie Mbh | A method of providing a waxy water-based emulsion for producing a wood-containing structure |
US10874122B2 (en) | 2012-02-10 | 2020-12-29 | Virun, Inc. | Beverage compositions containing non-polar compounds |
US9375490B2 (en) | 2012-03-30 | 2016-06-28 | Sancilio & Company, Inc. | Stable micelles of fatty acid esters for the treatment of disease states |
US10898458B2 (en) | 2012-03-30 | 2021-01-26 | Micelle Biopharma, Inc. | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states |
US9480651B2 (en) | 2012-03-30 | 2016-11-01 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms |
US9370585B2 (en) | 2012-03-30 | 2016-06-21 | Sancilio & Company, Inc. | Stable micelles of mixed fatty acids |
US9364558B2 (en) | 2012-03-30 | 2016-06-14 | Sancilio & Company, Inc. | Stable micelles of fatty acid esters for the treatment of cardiovascular disease |
US9364560B2 (en) | 2012-03-30 | 2016-06-14 | Sancilio & Company, Inc. | Stable micelles of fatty acid esters for the treatment of non-alcoholic fatty liver diseases |
US10894027B2 (en) | 2012-03-30 | 2021-01-19 | Micelle Biopharma, Inc. | Sickle cell disease treatment utilizing omega-3 fatty acids |
US9302017B2 (en) | 2012-03-30 | 2016-04-05 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
US9302016B2 (en) | 2012-03-30 | 2016-04-05 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
US9364562B2 (en) | 2012-03-30 | 2016-06-14 | Sancilio & Company, Inc. | Functional foods and kits containing stable micelles of fatty acid esters |
US9364561B2 (en) | 2012-03-30 | 2016-06-14 | Sancilio & Company, Inc | Stable micelles of fatty acid esters for the treatment of macular degeneration and primary sclerosing cholangitis |
US9364559B2 (en) | 2012-03-30 | 2016-06-14 | Sancilio & Company, Inc. | Stable micelles of fatty acid esters |
US10287528B2 (en) | 2012-03-30 | 2019-05-14 | Micelle Biopharma, Inc. | Omega-3 fatty acid ester compositions |
US9351517B2 (en) | 2013-03-15 | 2016-05-31 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and compositions containing same |
US9693574B2 (en) | 2013-08-08 | 2017-07-04 | Virun, Inc. | Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch |
US11382980B2 (en) * | 2013-10-08 | 2022-07-12 | Taiyo Kagaku Co., Ltd. | Oil/fat composition containing polyunsaturated fatty acid |
US10285971B2 (en) | 2014-09-18 | 2019-05-14 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same |
US10016363B2 (en) | 2014-09-18 | 2018-07-10 | Virun, Inc. | Pre-spray emulsions and powders containing non-polar compounds |
US9861611B2 (en) | 2014-09-18 | 2018-01-09 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same |
US20190014808A1 (en) * | 2016-04-14 | 2019-01-17 | Clover Corporation Limited | Methods of manufacturing nutritional formulations |
US20210277320A1 (en) * | 2018-07-02 | 2021-09-09 | Innospec Limited | Compositions, Uses and Methods for Improving The Low Temperature Properties of a Middle Distillate Fuel |
US20200325342A1 (en) * | 2019-04-12 | 2020-10-15 | Viavi Solutions Inc. | Method for manufacturing a special effect pigment using an emulsion |
US11655374B2 (en) * | 2019-04-12 | 2023-05-23 | Viavi Solutions Inc. | Method for manufacturing a special effect pigment using an emulsion |
US11571379B2 (en) * | 2020-01-24 | 2023-02-07 | The Procter & Gamble Company | Skin care composition |
WO2023146984A1 (en) * | 2022-01-26 | 2023-08-03 | Amarin Pharmaceuticals Ireland Limited | Lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment |
Also Published As
Publication number | Publication date |
---|---|
AU2009203200A1 (en) | 2009-08-27 |
AU2003238264A1 (en) | 2003-12-31 |
CA2489391A1 (en) | 2003-12-24 |
WO2003105606A1 (en) | 2003-12-24 |
AU2003238264B2 (en) | 2009-05-21 |
JP2006305569A (en) | 2006-11-09 |
EP1531687A4 (en) | 2006-11-15 |
JP2011255373A (en) | 2011-12-22 |
JP4913477B2 (en) | 2012-04-11 |
EP1531687A1 (en) | 2005-05-25 |
JP2005529728A (en) | 2005-10-06 |
US8529979B2 (en) | 2013-09-10 |
US20100298435A1 (en) | 2010-11-25 |
EP2368445A1 (en) | 2011-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8529979B2 (en) | Stable emulsions of oils in aqueous solutions and methods for producing same | |
JP3414530B2 (en) | Stable emulsified composition and food containing it | |
KR100343664B1 (en) | Stable emulsified compositions and foods containing the same | |
US20090324636A1 (en) | Fish oil in stabilized form | |
JP2005529728A5 (en) | ||
JP2007525976A (en) | Method for preserving foods and compositions comprising one or more phytosterols and / or phytostanols useful for this purpose | |
Magri et al. | Self-assembled lipids for food applications: A review | |
Jacobsen | Oxidative stability and shelf life of food emulsions | |
US20150133553A1 (en) | Emulsion comprising polyunsaturated fatty acids | |
JPWO2013122122A1 (en) | Milk beverage and method for producing the same | |
TW201832670A (en) | Chocolate-like food containing highly unsaturated fatty acid, said food configured to suppress generation of unfavorable flavors | |
JPH06169735A (en) | Nutritious drink composition | |
EP3213640A1 (en) | Long-chain polyunsaturated fatty-acid-containing fat and food containing same | |
JP2016186002A (en) | Antioxidant | |
Shahidi et al. | Marine lipids as affected by processing and their quality preservation by natural antioxidants | |
JP2006124488A (en) | Aqueous dispersion of highly unsaturated fatty acid-containing phospholipid | |
JP6891031B2 (en) | Emulsified liquid seasoning | |
JP2009225724A (en) | Composition containing arachidonic acid | |
JP3422338B2 (en) | Powdered beverage containing highly unsaturated fatty acids | |
WO2020236075A1 (en) | Increasing stability of lc-pufa | |
O'Dwyer | Stabilisation of omega-3 oils in food and emulsion systems | |
JPH0739302A (en) | Highly unsaturated fatty acid-containing fat and oil composition and highly unsaturated fatty acid-containing aqueous food | |
JP2022088160A (en) | Oil-in-water emulsion composition | |
RU2239326C2 (en) | Butter production process | |
CZ3185U1 (en) | Dairy and cosmetic articles containing vegetable oils |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MARTEK BIOSCIENCES CORPORATION, MARYLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ABRIL, JESUS RUBEN;STAGNITTI, GEORGE E.;REEL/FRAME:016175/0836 Effective date: 20050227 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |